trending Market Intelligence /marketintelligence/en/news-insights/trending/tzjytzlljhooi4cvez7ybg2 content esgSubNav
In This List

DiaMedica Therapeutics appoints chief medical officer

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


DiaMedica Therapeutics appoints chief medical officer

Minneapolis-based biotechnology company DiaMedica Therapeutics Inc. appointed Harry Alcorn Jr. as chief medical officer.

Alcorn previously served as chief scientific officer at DaVita Clinical Research. He has also served on the boards of the Association of Clinical Pharmacology Units and MEDTOX Laboratories Inc.

DiaMedica develops treatments for neurological and kidney diseases.